NASDAQ$SIGA

SIGA Technologies, Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

SIGA Technologies experienced a decrease in revenue and shifted to a net loss in Q3 2023.

SIGA Technologies reported a significant decrease in revenue for the third quarter of 2023, moving from $72.2 million in 2022 to $9.2 million. This resulted in a net loss of $0.4 million, a stark contrast to the $33.0 million net income reported in the same quarter of the previous year. The diluted loss per share was $0.01, compared to a diluted income per share of $0.45 in Q3 2022.

  • Total revenue decreased to $9.2 million compared to $72.2 million in the same quarter last year.
  • Net loss was $0.4 million, a significant change from the $33.0 million net income in Q3 2022.
  • Diluted loss per share was $0.01, compared to a diluted income per share of $0.45 in Q3 2022.
  • The company anticipates approximately $18 million in initial orders for oral TPOXX by EU countries under a new joint procurement framework contract.

Headline financials

Total Revenue

$9.24M

Previous: $72.2M-87.2%
EPS (adj)

-$0.01

Previous: $0.45-102.2%
Capital Expenditures

-$21.7K

Previous: $0.00
Free Cash Flow

-$415K

Previous: $33M-101.3%
Net Income

-$393K

Previous: $33M-101.2%
Operating Income

-$1.31M

Previous: $42.9M-103.1%
Gross Profit

$8.34M

Previous: $68.3M-87.8%
Cash & Equivalents

$71.1M

Previous: $110M-35.2%
Total Assets

$158M

Previous: $204M-22.4%
R&D Expense

$3.65M

No prior period
Stock-Based Comp

$460K

Previous: $329K+39.9%

Revenue & EPS history

SIGA Technologies · Revenue · Quarterly

$9.24M

Q3 2023-87.2%vs Q3 2022
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Revenue by segment

SIGA Technologies · $9.24M total across 2 segments · Q3 2023

  • Product Sales
    $7.96M-87.9%
  • R&D Revenues
    $1.28M-80.6%

Forward guidance

SIGA Technologies anticipates full year 2023 pre-tax operating income of between $90 million and $100 million as they are targeting the delivery of approximately $113 million of oral TPOXX to the stockpile in the fourth quarter.

Tailwinds

  • Targeting the delivery of approximately $113 million of oral TPOXX to the U.S. strategic national stockpile in Q4.
  • Targeting $15 million - $18 million of international deliveries of oral TPOXX in Q4.
  • Targeting the delivery of approximately $5 million of oral TPOXX to the U.S. Department of Defense in Q4.
  • Targeting deliveries of up to $15 million of IV TPOXX to the strategic national stockpile in Q4.
  • Expecting any target deliveries and related revenues that do not occur in Q4 to occur in January of 2024.

Headwinds

  • Financial results reflect a relatively minor percentage of full year target revenues.
  • Potential delays due to timing constraints with customers or packaging vendor.
  • Risk that BARDA may not exercise all remaining unexercised options under the BARDA Contract.
  • Risk that SIGA may not complete performance under the BARDA Contract on schedule or in accordance with contractual terms.
  • Risk of disruptions to SIGA’s supply chain for the manufacture of TPOXX®.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

26 / 64 earnings

Positive

+31.9%

Q4 2023

Best reaction

-27.8%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.4%-5.5%-8.5%
Q4 2025-3.0%-3.4%-22.8%
Q3 2025-20.2%-24.0%-24.1%
Q1 2025+4.4%+9.0%+10.8%
Q4 2024+7.0%+0.5%+6.4%
Q3 2024-1.9%-8.5%-9.8%
Q2 2024-12.8%-14.3%-9.5%
Q1 2024-27.8%-28.2%-26.7%
Q4 2023+31.9%+49.9%+88.3%
Q3 2023-4.4%-2.2%+16.9%
Q2 2023-3.7%-10.0%-21.9%
Q1 2023+5.1%+1.8%-0.7%
Q4 2022-3.8%-7.8%-13.4%
Q3 2022+7.5%+9.8%+1.1%
Q2 2022+27.4%+24.6%-21.0%
Q1 2022+3.6%+4.0%+60.7%
Q4 2021+3.0%+6.6%+22.4%
Q3 2021-0.7%+0.0%+2.8%
Q2 2021-2.9%-4.0%+9.1%
Q1 2021-0.7%-8.4%-10.4%
Q4 2020+1.7%+9.3%+1.2%
Q3 2020+2.0%+3.4%-0.9%
Q2 2020+14.3%+5.5%-1.9%
Q1 2020-1.4%+1.4%+2.9%
Q4 2019+10.4%+0.4%+0.2%
Q3 2019-3.2%-1.8%-19.8%
Q2 2019+0.2%-1.7%+2.7%
Q1 2019+1.5%-1.3%-12.8%
Q4 2018-4.4%-1.6%-6.3%
Q3 2018+8.4%+5.7%+29.1%
Q2 2018+0.3%+7.7%+1.4%
Q1 2018-0.5%+2.4%-3.9%
Q4 2017-0.6%-7.0%-2.3%
Q3 2017+2.8%-1.1%+3.9%
Q2 2017-1.6%-1.6%-1.9%
Q1 2017-0.3%+0.6%-8.0%
Q4 2016-0.6%+0.0%-4.1%
Q3 2016-5.7%+3.8%+54.8%
Q2 2016+4.5%+4.1%+11.4%
Q1 2016+1.1%
Q4 2015+1.1%
Q3 2015+2.4%
Q2 2015-0.9%
Q1 2015+5.7%
Q4 2014-1.3%
Q3 2014-0.7%
Q2 2014-4.9%
Q1 2014-1.4%
Q4 2013-2.7%
Q3 2013-3.5%
Q2 2013-2.8%
Q1 2011-2.4%
Q4 2012-2.5%
Q3 2012+6.5%
Q2 2012+5.3%
Q1 2012+4.5%
Q4 2011-1.4%
Q4 2009-1.4%
Q3 2010-6.1%
Q3 2011-6.1%
Q2 2011-12.0%
Q2 2010-12.0%
Q4 2010-12.0%
Q1 2010-1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro